Skip to search.
 TSX Up 0.13% TSX Ventures Down 0.17%

Novartis AG (NVS)

-NYSE
98.95 Down 0.09(0.09%) Mar 5, 4:02PM EST
Add to Portfolio
Prev Close:99.04
Open:99.18
Bid:98.68 x 2000
Ask:98.85 x 4000
1y Target Est:104.57
Beta:0.65
Next Earnings Date:N/A
Day's Range:98.48 - 99.50
52wk Range:80.64 - 103.50
Volume:1,498,322
Avg Vol (3m):1,983,840
Market Cap:237.34B
P/E (ttm):23.96
EPS (ttm):4.13
Div & Yield:2.82 (2.80%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVSDown 0.09%237.34B
MRKUp 0.17%164.56B
PFEDown 0.49%211.26B
SNYUp 0.04%127.26B

Key Statistics

Forward P/E (1 yr):17.83
P/S (ttm):4.43
Ex-Dividend Date:02-Mar-15

Analysts

Annual EPS Est (Dec-15) :5.21
Quarterly EPS Est (Mar-15) :1.07
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):2.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback